Update on Over-the-Counter (OTC) Contraception
Date Added:
October 23, 2024
Journal/Publication:
JAMA
Publication Date:
October 9, 2024
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Web Page
Abstract
In July 2023, the US Food and Drug Administration (FDA) approved Opill, a daily progestin-only oral contraceptive for over-the-counter sale to people of all ages. Daniel Grossman, MD, discusses this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH.
Text Availability
Free full text
RPR Commentary
A 13-minute audiotape reviewing the new OTYC progestin-only oral contraceptive. James W. Mold, MD, MPH